Delta Dental Invests in Interleukin Genetics to Advance Periodontal Disease Susceptibility Risk Test

Michigan-based Delta Dental invests 3 million USD in Interleukin Genetics to further research and develop their periodontal disease susceptibility risk test. The risk test forms part of Interleukin Genetics’ Inherent Health and Periodontal Disease Test (PST) product development, supported by Delta Dental Plan of Michigan Inc. The periodontal disease susceptibility risk test is designed to […]